Targeting Vascular and Leukocyte Communication in Angiogenesis, Inflammation and Fibrosis

Overview

Journal Nat Rev Drug Discov

Specialty Pharmacology

Date 2015 Nov 28

PMID 26612664

Citations 63

Authors

Johan Kreuger

Mia Phillipson

Affiliations

Soon will be listed here.

Abstract

Regulation of vascular permeability, recruitment of leukocytes from blood to tissue and angiogenesis are all processes that occur at the level of the microvasculature during both physiological and pathological conditions. The interplay between microvascular cells and leukocytes during inflammation, together with the emerging roles of leukocytes in the modulation of the angiogenic process, make leukocyte-vascular interactions prime targets for therapeutics to potentially treat a wide range of diseases, including pathological and dysfunctional vessel growth, chronic inflammation and fibrosis. In this Review, we discuss how the different cell types that are present in and around microvessels interact, cooperate and instruct each other, and in this context we highlight drug targets as well as emerging druggable processes that can be exploited to restore tissue homeostasis.

Citing Articles

Targeted Polymer-Peptide Conjugates for E-Selectin Blockade in Renal Injury.

Milosevic N, Rutter M, Ventura Y, Feinshtein V, David A Pharmaceutics. 2025; 17(1).

PMID: 39861730 PMC: 11768228. DOI: 10.3390/pharmaceutics17010082.

Immunoregulative coating for scarless healing in anterior cruciate ligament reconstruction.

Wang S, Xu C, Yu Y, Li J, Chen T, Wang J Bioact Mater. 2024; 45:71-87.

PMID: 39624422 PMC: 11609481. DOI: 10.1016/j.bioactmat.2024.11.007.

Implants coating strategies for antibacterial treatment in fracture and defect models: A systematic review of animal studies.

Li B, Thebault P, Labat B, Ladam G, Alt V, Rupp M J Orthop Translat. 2024; 45:24-35.

PMID: 38495742 PMC: 10943307. DOI: 10.1016/j.jot.2023.12.006.

Self-assembled and perfusable microvasculature-on-chip for modeling leukocyte trafficking.

Hirth E, Cao W, Peltonen M, Kapetanovic E, Dietsche C, Svanberg S Lab Chip. 2023; 24(2):292-304.

PMID: 38086670 PMC: 10793075. DOI: 10.1039/d3lc00719g.

Reprogramming endothelial cells to empower cancer immunotherapy.

Cleveland A, Fan Y Trends Mol Med. 2023; 30(2):126-135.

PMID: 38040601 PMC: 10922198. DOI: 10.1016/j.molmed.2023.11.002.

References

Mantovani A . Molecular pathways linking inflammation and cancer. Curr Mol Med. 2010; 10(4):369-73. DOI: 10.2174/156652410791316968. View

Fox D . Kinase inhibition--a new approach to the treatment of rheumatoid arthritis. N Engl J Med. 2012; 367(6):565-7. DOI: 10.1056/NEJMe1206315. View

Barone A, Sengupta R, Warrington N, Smith E, Wen P, Brekken R . Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma. Oncotarget. 2014; 5(20):9811-22. PMC: 4259439. DOI: 10.18632/oncotarget.2443. View

Seki E, De Minicis S, Osterreicher C, Kluwe J, Osawa Y, Brenner D . TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007; 13(11):1324-32. DOI: 10.1038/nm1663. View

Xu H, Zhu J, Smith S, Foldi J, Zhao B, Chung A . Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat Immunol. 2012; 13(7):642-50. PMC: 3513378. DOI: 10.1038/ni.2304. View

Wang H, Chen Z, Anderson D . Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 1998; 93(5):741-53. DOI: 10.1016/s0092-8674(00)81436-1. View

Kelly-Goss M, Sweat R, Stapor P, Peirce S, Murfee W . Targeting pericytes for angiogenic therapies. Microcirculation. 2013; 21(4):345-57. PMC: 4079092. DOI: 10.1111/micc.12107. View

Wilhelm S, Carter C, Tang L, Wilkie D, McNabola A, Rong H . BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 2004; 64(19):7099-109. DOI: 10.1158/0008-5472.CAN-04-1443. View

Westphalen K, Gusarova G, Islam M, Subramanian M, Cohen T, Prince A . Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature. 2014; 506(7489):503-6. PMC: 4117212. DOI: 10.1038/nature12902. View

10.

Claesson-Welsh L, Welsh M . VEGFA and tumour angiogenesis. J Intern Med. 2012; 273(2):114-27. DOI: 10.1111/joim.12019. View

11.

Allavena P, Peccatori F, Maggioni D, Erroi A, Sironi M, Colombo N . Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells. Cancer Res. 1990; 50(22):7318-23. View

12.

Sica A, Mantovani A . Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012; 122(3):787-95. PMC: 3287223. DOI: 10.1172/JCI59643. View

13.

Jain R . Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med. 2001; 7(9):987-9. DOI: 10.1038/nm0901-987. View

14.

Massena S, Christoffersson G, Vagesjo E, Seignez C, Gustafsson K, Binet F . Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood. 2015; 126(17):2016-26. PMC: 4616235. DOI: 10.1182/blood-2015-03-631572. View

15.

Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M . Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med. 2005; 353(4):362-8. DOI: 10.1056/NEJMoa051586. View

16.

Hirschi K, Burt J, Hirschi K, Dai C . Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation. Circ Res. 2003; 93(5):429-37. DOI: 10.1161/01.RES.0000091259.84556.D5. View

17.

Lindahl P, Johansson B, Leveen P, Betsholtz C . Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997; 277(5323):242-5. DOI: 10.1126/science.277.5323.242. View

18.

Wu J, Staton C . Anti-angiogenic drug discovery: lessons from the past and thoughts for the future. Expert Opin Drug Discov. 2012; 7(8):723-43. DOI: 10.1517/17460441.2012.695774. View

19.

Sims D . The pericyte--a review. Tissue Cell. 1986; 18(2):153-74. DOI: 10.1016/0040-8166(86)90026-1. View

20.

Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B . Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009; 136(5):839-851. PMC: 4037868. DOI: 10.1016/j.cell.2009.01.020. View